Breast Cancer | Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor

Featuring perspectives from Dr Adiyta Bardia and Dr Erika Hamilton, including the following topics:

• Introduction: Biopharmacology and Endocrinology of Breast Cancer (0:00)
• Current Strategies for Previously Treated ER-Positive Metastatic Breast Cancer (mBC) — Dr Bardia (12:15)
• Future Directions in the Management of ER-Positive mBC — Dr Hamilton (33:16)
• Clinical Investigator Survey (51:50)

CME information and select publications